Peter M Scarbrough1, Igor Akushevich1, Margaret Wrensch2, Dora Il'yasova3. 1. Duke Cancer Institute, Duke University Medical Center, Durham, NC. 2. Department of Neurological Surgery, University of California, San Francisco, San Francisco. 3. Duke Cancer Institute, Duke University Medical Center, Durham, NC; Division of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta. Electronic address: dilyasova@gsu.edu.
Abstract
PURPOSE: Gliomas are one of the most fatal malignancies, with largely unknown etiology. This study examines a possible connection between glioma and melanoma, which might provide insight into gliomas' etiology. METHODS: Using data provided by the Surveillance, Epidemiology, and End Results program from 1992 to 2009, a cohort was constructed to determine the incidence rates of glioma among those who had a prior diagnosis of invasive melanoma. Glioma rates in those with prior melanoma were compared with those in the general population. RESULTS: The incidence rate of all gliomas was greater among melanoma cases than in the general population: 10.46 versus 6.13 cases per 100,000 person-years, standardized incidence ratios = 1.42 (1.22-1.62). The female excess rate was slightly greater (42%) than that among males (29%). Sensitivity analyses did not reveal evidence that radiation treatment of melanoma is responsible for the detected gap in the rates of gliomas. CONCLUSIONS: Our analysis documented increased risk of glioma among melanoma patients. Because no common environmental risk factors are identified for glioma and melanoma, it is hypothesized that a common genetic predisposition may be responsible for the detected association.
PURPOSE:Gliomas are one of the most fatal malignancies, with largely unknown etiology. This study examines a possible connection between glioma and melanoma, which might provide insight into gliomas' etiology. METHODS: Using data provided by the Surveillance, Epidemiology, and End Results program from 1992 to 2009, a cohort was constructed to determine the incidence rates of glioma among those who had a prior diagnosis of invasive melanoma. Glioma rates in those with prior melanoma were compared with those in the general population. RESULTS: The incidence rate of all gliomas was greater among melanoma cases than in the general population: 10.46 versus 6.13 cases per 100,000 person-years, standardized incidence ratios = 1.42 (1.22-1.62). The female excess rate was slightly greater (42%) than that among males (29%). Sensitivity analyses did not reveal evidence that radiation treatment of melanoma is responsible for the detected gap in the rates of gliomas. CONCLUSIONS: Our analysis documented increased risk of glioma among melanomapatients. Because no common environmental risk factors are identified for glioma and melanoma, it is hypothesized that a common genetic predisposition may be responsible for the detected association.
Authors: Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler Journal: Cancer Date: 2008-10-01 Impact factor: 6.860
Authors: Niina Paunu; Eero Pukkala; Pekka Laippala; Risto Sankila; Jorma Isola; Helena Miettinen; Kalle O J Simola; Pauli Helén; Heikki Helin; Hannu Haapasalo Journal: Int J Cancer Date: 2002-02-20 Impact factor: 7.396
Authors: Peter D Inskip; Robert E Tarone; Elizabeth E Hatch; Timothy C Wilcosky; Howard A Fine; Peter M Black; Jay S Loeffler; William R Shapiro; Robert G Selker; Martha S Linet Journal: Int J Epidemiol Date: 2003-04 Impact factor: 7.196
Authors: Michael E Scheurer; Carol J Etzel; Mei Liu; Randa El-Zein; Gladstone E Airewele; Beatrice Malmer; Kenneth D Aldape; Jeffrey S Weinberg; W K Alfred Yung; Melissa L Bondy Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-11 Impact factor: 4.254
Authors: Victoria Zigmont; Amy Garrett; Jin Peng; Michal Seweryn; Grzegorz A Rempala; Randall Harris; Christopher Holloman; Thomas E Gundersen; Anders Ahlbom; Maria Feychting; Tom Borge Johannesen; Tom Kristian Grimsrud; Judith Schwartzbaum Journal: Nutr Cancer Date: 2015-08-28 Impact factor: 2.900
Authors: Gang Che; Bingjiang Huang; Zhinan Xie; Jingjing Zhao; Yan Yan; Jinna Wu; Huanhuan Sun; Haiqing Ma Journal: Am J Cancer Res Date: 2019-07-01 Impact factor: 6.166
Authors: Quinn T Ostrom; Warren Coleman; William Huang; Joshua B Rubin; Justin D Lathia; Michael E Berens; Gil Speyer; Peter Liao; Margaret R Wrensch; Jeanette E Eckel-Passow; Georgina Armstrong; Terri Rice; John K Wiencke; Lucie S McCoy; Helen M Hansen; Christopher I Amos; Jonine L Bernstein; Elizabeth B Claus; Richard S Houlston; Dora Il'yasova; Robert B Jenkins; Christoffer Johansen; Daniel H Lachance; Rose K Lai; Ryan T Merrell; Sara H Olson; Siegal Sadetzki; Joellen M Schildkraut; Sanjay Shete; Ulrika Andersson; Preetha Rajaraman; Stephen J Chanock; Martha S Linet; Zhaoming Wang; Meredith Yeager; Beatrice Melin; Melissa L Bondy; Jill S Barnholtz-Sloan Journal: Neuro Oncol Date: 2019-01-01 Impact factor: 12.300